PetMed Express Files 8-K on Executive Changes

Ticker: PETS · Form: 8-K · Filed: 2025-04-09T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, board-composition, regulation-fd

Related Tickers: PETS

TL;DR

PETS leadership shakeup and compensation details filed today.

AI Summary

PetMed Express, Inc. filed an 8-K on April 9, 2025, reporting on the departure of directors, election of directors, appointment of officers, and compensatory arrangements. The filing also includes a Regulation FD Disclosure, indicating important information is being shared with the public.

Why It Matters

This filing signals potential shifts in the company's leadership and compensation structures, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directorship and officers, along with compensatory arrangements, can indicate internal shifts that may affect company performance or strategy.

Key Players & Entities

FAQ

What specific items are being reported in this 8-K filing?

This 8-K filing reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, compensatory arrangements of certain officers, and includes a Regulation FD Disclosure.

What is the exact name of the registrant?

The exact name of the registrant is PetMed Express, Inc.

On what date was this report filed?

The report was filed as of April 9, 2025.

In which state was PetMed Express, Inc. incorporated?

PetMed Express, Inc. was incorporated in Florida.

What is the address of the principal executive offices?

The address of the principal executive offices is 420 South Congress Avenue, Delray Beach, Florida 33445.

From the Filing

0001040130-25-000016.txt : 20250409 0001040130-25-000016.hdr.sgml : 20250409 20250409092445 ACCESSION NUMBER: 0001040130-25-000016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250409 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250409 DATE AS OF CHANGE: 20250409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 25824029 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20250409.htm 8-K pets-20250409 0001040130 FALSE 0001040130 2025-04-09 2025-04-09 0001040130 us-gaap:CommonStockMember 2025-04-09 2025-04-09 0001040130 us-gaap:PreferredStockMember 2025-04-09 2025-04-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  April 9, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Director On April 9, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved the appointment of Peter Batushansky to serve as a director of the Company beginning April 9, 2025. Mr. Batushansky will hold this position until the 2025 annual meeting of the Company’s shareholders or until his successor is elected and qualified, subject to his earlier resignation or removal. Mr. B

View on Read The Filing